Metallothionein isoform 3 expression inhibits cell growth and increases drug resistance of PC-3 prostate cancer cells

Prostate

Volumn 52, Issue 2, 2002, Pages 89-97

  Dutta, Rana ^a   Sens, Donald A ^a,b   Somji, Seema ^a,b   Sens, Mary Ann ^a   Garrett, Scott H ^a,b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell growth; Drug resistance; Metallothionein; MT 3; PC 3; Prostate cancer

Indexed keywords

CISPLATIN; ETOPOSIDE; ISOPROTEIN; METALLOTHIONEIN; METALLOTHIONEIN ISOFORM 3; MITOXANTRONE; PACLITAXEL; UNCLASSIFIED DRUG; VINBLASTINE;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL GROWTH; COLONY FORMATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM;

CELL DIVISION; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; GROWTH INHIBITORS; HUMANS; MALE; NERVE TISSUE PROTEINS; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0036602802     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10097     Document Type: Article

References (23)

1. The growth inhibitory factor that is deficient in Alzheimer's disease is a 68 amino acid metallothionein-like protein
2. Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease
3. MT-III a brain-specific member of the metallothionein gene family
4. ID receptor genes
5. The bioactivity of metallothionein-3 correlates with its novel β domain sequence rather than metal binding properties
6. Metallothioneins in brain- the role in physiology and pathology
7. Expression of MT-3 protein in the human kidney
8. Metallothionein isoform 3 expression in the human prostate and cancer-derived cell lines
9. Metallothionein Isoform 3 as a potential biomarker for human bladder cancer
10. Metallothionein isoform 3 (MT-3) overexpression is associated with breast cancers having a poor prognosis
11. Metallothionein isoform 1 and 2 gene expression in the human prostate: Down-regulation of MT-1X in advance prostate cancer
12. Induction of metallothionein mRNA and protein in primary murine neuron cultures
13. Transgenic expression of interleukin 6 in the central nervous system regulates brain metallothionein-I and -III expression in mice
14. Regulation of metallothionein-3 mRNA by thyroid hormone in developing rat brain and primary cultures of rat astrocytes and neurons
15. Stimulatory effects of 4-methylcatechol, dopamine and levodopa on the expression of metallothionein-III (GIF) mRNA in immortalized mouse brain glial cells (VG-2g)
16. Characterization of cis-acting elements in the promoter of the mouse metallothionein-3 gene
17. Constitutive expression of metallothionein-III (MT-III), but not MT-1, inhibits growth when cells become zinc deficient
18. Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer
19. Inhibitory effect of zinc on human prostatic carcinoma cell growth
20. Metallothionein-III antagonizes the neurotoxic and neurotrophic effects of amyloid β peptides
21. Metallothioneins and cell death by anticancer drugs
22. The protein thiol metallothionein as an antioxidant and protectant against antineoplastic drugs
23. Metallothionein acts as a cytoprotectant against doxorubicin toxicity